# Reinsurance Group of America (RGA)

Sector: Life and health reinsurance

| Field | Value |
|---|---|
| Price | $266.83 |
| Market cap | $17B |
| Intrinsic value source | AI estimate |
| Data as of | 2026-11-20 |
| Next earnings | 2027-02-05 (estimate) |

Analysts: Leaning bullish

Picks: Research only

Discount category: Below intrinsic value

## In short

The market doubts that the strong 2026 returns of Reinsurance Group of America can last, and steady claims results with good returns on new in-force deals through 2027 can lift its value.

## Themes and gap

- Themes: Interest rates (interest-rates), New management (management-change)
- Gap type: Can close (closable)
- Why: The Q4 2026 report, expected in February 2027, and the next quarters show whether the return on equity stays high when variable investment income returns to normal.

## About

Reinsurance Group of America, Incorporated (RGA) is based in St. Louis, Missouri. It is a global reinsurer of life and health risks. It takes mortality, morbidity and longevity risk from insurance companies, and its Financial Solutions business reinsures blocks of in-force policies and takes on pension risk. Its segments are U.S. and Latin America, Canada, Europe, Middle East and Africa, Asia Pacific, and Corporate and Other. Net premiums were $14,419 million in the first nine months of 2026, and total assets were $169,520 million at September 30, 2026. The common stock trades on the NYSE in US dollars. RGA files 10-K and 10-Q reports.

## Thesis

The market gives RGA a low multiple of its earnings, because the profit of a reinsurer depends on long-term assumptions about mortality, claims and investment returns that investors cannot check. Results in 2026 were strong: adjusted operating income was $24.34 per diluted share in the first nine months, and the adjusted operating return on equity was 19.2% for the last twelve months. Strong variable investment income and favorable claims helped these results, so investors ask if they can last. The AI estimate rests on three conditions. The adjusted operating return on equity must stay near 16% or more when variable investment income returns to normal. The annual actuarial assumption reviews must not cause large charges, and the 2026 review had no net effect. RGA must keep finding in-force block and pension risk deals with good returns. The Q4 2026 report, expected in February 2027, is the next test. A large claims event or losses in the credit portfolio can reduce book value.

## Checkpoints

- Feb 5, 2027 (estimate): Q4 2026 results. Status: Pending. Watch: The adjusted operating return on equity without notable items stays at 15% or more for 2026, and this passes; a large claims charge or a return below 13% fails.
- Q3 2027 (estimate): 2027 actuarial assumption review. Status: Pending. Watch: The annual review has no large negative net effect on adjusted operating income, and this passes; a large charge fails.

## Valuation

The intrinsic value for Reinsurance Group of America is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of RGA with the SEC. The method is a multiple of book value per share without accumulated other comprehensive income (AOCI). The multiple is the return on equity minus long-term growth, divided by the cost of equity minus long-term growth. Book value is after debt, so the estimate makes no debt adjustment, and it is per share. The Q3 2026 release (8-K, November 5, 2026) gives adjusted operating income of $8.49 per diluted share for Q3 and $24.34 for nine months. It gives an adjusted operating return on equity of 19.2%, and 19.1% without notable items, for the last twelve months, and book value per share without AOCI of $179.51 at September 30, 2026. The Q4 2025 release (8-K, February 5, 2026) gives an adjusted operating return on equity without notable items of 15.7% for 2025. The Form 10-Q for the quarter ended September 30, 2026 gives long-term debt of $5,310 million and shareholders' equity of $11,636 million, and its cover gives 65,049,910 shares at October 26, 2026. The return on equity, a cost of equity of 10.5% and long-term growth of 4% are assumptions. The low case assumes a return of 12.5%, because variable investment income falls and claims rise, so the multiple is 1.31 times. It gives $235.16 per share. The base case assumes 16%, close to the 2025 result without notable items, so the multiple is 1.85 times. It gives $332.09 per share. The high case assumes 19%, close to the 2026 result, so the multiple is 2.31 times. It gives $414.67 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $328.50 per share. RGA has long client relationships, large mortality data and treaties that last for decades, which make it hard for a new reinsurer to take its clients, but a few large reinsurers compete for the same business on price.

As of 2026-11-14.

Sources:

- https://www.sec.gov/Archives/edgar/data/898174/000089817426000038/pressrelease3q26.htm
- https://www.sec.gov/Archives/edgar/data/898174/000089817426000040/rga-20260930.htm
- https://www.sec.gov/Archives/edgar/data/898174/000089817426000003/pressrelease4q25.htm

## Balance sheet

- Cash: $4.6B
- Debt: $5.3B
- Net debt: $662M
- Last debt due: 2056

At September 30, 2026, RGA had total assets of $169,520 million, mostly investments, with fixed maturity securities of $107,757 million at fair value. Cash and cash equivalents were $4,648 million. Long-term debt was $5,310 million, down from $5,710 million at December 31, 2025. RGA issued $400 million of 6.375% debentures due 2056 in March 2026 and redeemed $400 million of 5.75% debentures in June 2026. Shareholders' equity was $11,636 million. Book value per share was $178.89, and $179.51 without accumulated other comprehensive income. Much of the cash supports the reinsurance obligations, so it is not all free to repay debt.

As of 2026-09-30.

Sources:

- https://www.sec.gov/Archives/edgar/data/898174/000089817426000040/rga-20260930.htm
- https://www.sec.gov/Archives/edgar/data/898174/000089817426000038/pressrelease3q26.htm

## Dividends

- Dividend yield: 1.1% (last 12 months, at the current price)
- Paid per share, last 12 months: $2.84 (3 payments; a usual year has 4)
- Current annual rate: $3.92 ($0.98 x 4 a year)
- Payout ratio: 21% of the earnings of the last fiscal year (the year ended 2025-12-31)
- Latest ex-dividend date: 2026-08-18, $0.98 per share
- Growth from 2020 to 2025: 5.4% a year
- Growth from 2016 to 2025: 9.9% a year

Dividends per share by year: 2016: $1.56, 2017: $1.82, 2018: $2.20, 2019: $2.60, 2020: $2.80, 2021: $2.86, 2022: $3.06, 2023: $3.30, 2024: $3.48, 2025: $3.64.

Source: company filings and market data, read on 2026-11-13.

## Recent events

- 2026-11-05: RGA reported Q3 2026 results. Net income was $6.92 per diluted share and adjusted operating income was $8.49 per diluted share, up from $4.66. Net premiums rose 25.0% to $5.4 billion, with about $800 million from single premium pension risk transfer deals. The annual actuarial assumption review had no net effect on adjusted operating income. RGA returned $139 million to shareholders in the quarter.
- 2026-08-06: RGA reported Q2 2026 results, with adjusted operating income of $8.89 per diluted share, up from $4.72. The board raised the quarterly dividend by 5.4% to $0.98 per share.
- 2026-06-22: Laura Cockrill, the Chief Strategy Officer, became CFO, after CFO Axel André resigned with effect from July 17, 2026.
- 2026-06-15: RGA redeemed all $400 million of its 5.75% fixed-to-floating rate subordinated debentures due 2056 at 100% of the principal.
- 2026-03-03: RGA issued $400 million of 6.375% fixed-rate reset subordinated debentures due 2056.
- 2026-02-05: RGA reported 2025 results. Adjusted operating income was $22.72 per diluted share, or $24.42 without notable items. It put $2.5 billion of capital into in-force block deals and estimated deployable capital of $3.4 billion at the end of 2025.

## Latest news and filings

- Last earnings: 2026-11-05 (8-K: https://www.sec.gov/Archives/edgar/data/898174/000089817426000038/)
- Next earnings: 2027-02-05 (expected; the company has not confirmed it)

| Filed | Form | Headline | Period end | XBRL document | Link |
| --- | --- | --- | --- | --- | --- |
| 2026-11-06 | 10-Q | Quarterly report for the period ended Sep 30, 2026 | 2026-09-30 | rga-20260930 | https://www.sec.gov/Archives/edgar/data/898174/000089817426000040/rga-20260930.htm |
| 2026-11-05 | 8-K | Earnings release and Investor disclosure |  | rga-20261105 | https://www.sec.gov/Archives/edgar/data/898174/000089817426000038/ |
| 2026-08-07 | 10-Q | Quarterly report for the period ended Jun 30, 2026 | 2026-06-30 | rga-20260630 | https://www.sec.gov/Archives/edgar/data/898174/000089817426000034/rga-20260630.htm |
| 2026-08-06 | 8-K | Earnings release and Investor disclosure |  | rga-20260806 | https://www.sec.gov/Archives/edgar/data/898174/000089817426000030/ |
| 2026-07-09 | 8-K | Change of directors or officers |  |  | https://www.sec.gov/Archives/edgar/data/898174/000119312526299825/d138283d8k.htm |
| 2026-07-01 | 8-K | Change of directors or officers and Investor disclosure |  |  | https://www.sec.gov/Archives/edgar/data/898174/000119312526292830/d108862d8k.htm |
| 2026-06-22 | 8-K | Change of directors or officers and Investor disclosure |  |  | https://www.sec.gov/Archives/edgar/data/898174/000119312526276808/d147490d8k.htm |
| 2026-05-21 | 8-K | Change of directors or officers and Shareholder vote results |  |  | https://www.sec.gov/Archives/edgar/data/898174/000119312526234445/d136842d8k.htm |
| 2026-05-08 | 10-Q | Quarterly report for the period ended Mar 31, 2026 | 2026-03-31 | rga-20260331 | https://www.sec.gov/Archives/edgar/data/898174/000089817426000025/rga-20260331.htm |
| 2026-05-07 | 8-K | Earnings release and Investor disclosure |  | rga-20260505 | https://www.sec.gov/Archives/edgar/data/898174/000089817426000022/ |

Every filing on SEC EDGAR (CIK 898174): https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000898174&type=&dateb=&owner=include&count=40

## Risks

- High: Results depend on mortality, morbidity and longevity assumptions over decades. A pandemic or a change in assumptions can cause large charges, as in Q3 2025, when EMEA Traditional had an adjusted operating loss before taxes of $192 million.
- Medium: RGA holds fixed maturity securities of $107,757 million at fair value. Credit losses can reduce book value, and the strong variable investment income of 2026 can fall.
- Medium: In-force block and pension risk deals are large and complex. Their returns depend on how RGA prices the risks and invests the assets that it receives.
- Low: RGA earns in many currencies. Currency changes reduced adjusted operating income by $0.15 per diluted share in Q3 2026.
- Low: RGA changed its CFO in 2026, and its Chief Information Officer left in April 2026.

## Links

- Page: https://picks.utilarium.app/company/RGA/
- History of changes: https://picks.utilarium.app/company/RGA/history/
- JSON with full history: https://picks.utilarium.app/data/company/RGA.json

> Picks is a personal record of stock picks. It gives general opinions about stocks, including a "Top pick" label. They are not tailored to your needs, goals or risk tolerance. Kevin is not a registered adviser and relies on the general-advice exemption in Canadian securities law (NI 31-103 s.8.25). Do your own research, or ask a registered adviser. Kevin may hold any stock on this site. Prices, intrinsic values and ratings can be delayed or wrong; check the original source. Full disclaimer: /disclaimer/.
